Korea paints too rosy picture for biosimilars development
Critics and industry sources said the government’s optimistic approach on biosimilars should be restrained in consideration of negative factor...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
